Literature DB >> 24515709

Excellent response to amantadine in a patient with bipolar disorder and catatonia.

Valerica Ene-Stroescu, Thanh Nguyen, Brian E Waiblinger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24515709     DOI： 10.1176/appi.neuropsych.13020038

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN： 0895-0172            Impact factor:   2.198


× No keyword cloud information.
  6 in total

Review 1.  A clinical review of the treatment of catatonia.

Authors:  Pascal Sienaert; Dirk M Dhossche; Davy Vancampfort; Marc De Hert; Gábor Gazdag
Journal:  Front Psychiatry       Date:  2014-12-09       Impact factor: 4.157

2.  The management of catatonia in bipolar disorder with stimulants.

Authors:  Waheed K Bajwa; Ali Rastegarpour; Omar A Bajwa; Jessica Babbitt
Journal:  Case Rep Psychiatry       Date:  2015-02-19

3.  The Lorazepam and Diazepam Protocol for Catatonia Due to General Medical Condition and Substance in Liaison Psychiatry.

Authors:  Chin-Chuen Lin; Yi-Yung Hung; Meng-Chang Tsai; Tiao-Lai Huang
Journal:  PLoS One       Date:  2017-01-23       Impact factor: 3.240

4.  Associations Between Amantadine Usage, Gait, and Cognition in PSP: A post-hoc Analysis of the Davunetide Trial.

Authors:  Marian L Dale; Barbara H Brumbach; Adam L Boxer; Amie L Hiller
Journal:  Front Neurol       Date:  2020-12-21       Impact factor: 4.003

Review 5.  Molecular and cellular mechanisms leading to catatonia: an integrative approach from clinical and preclinical evidence.

Authors:  Daniel Felipe Ariza-Salamanca; María Gabriela Corrales-Hernández; María José Pachón-Londoño; Isabella Hernández-Duarte
Journal:  Front Mol Neurosci       Date:  2022-09-29       Impact factor: 6.261

Review 6.  Neurobiological Approach of Catatonia and Treatment Perspectives.

Authors:  Pierre Ellul; Walid Choucha
Journal:  Front Psychiatry       Date:  2015-12-24       Impact factor: 4.157
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.